271 related articles for article (PubMed ID: 16204245)
21. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK
Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
[TBL] [Abstract][Full Text] [Related]
22. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
23. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.
Hong WC; Amara SG
FASEB J; 2013 Aug; 27(8):2995-3007. PubMed ID: 23612789
[TBL] [Abstract][Full Text] [Related]
24. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
Hall DA; Powers JP; Gulley JM
Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
[TBL] [Abstract][Full Text] [Related]
25. Extended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats.
D'Arcy C; Luevano JE; Miranda-Arango M; Pipkin JA; Jackson JA; Castañeda E; Gosselink KL; O'Dell LE
Behav Brain Res; 2016 Jan; 296():125-128. PubMed ID: 26367473
[TBL] [Abstract][Full Text] [Related]
26. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
[TBL] [Abstract][Full Text] [Related]
27. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the dopamine transporter by phosphorylation.
Foster JD; Cervinski MA; Gorentla BK; Vaughan RA
Handb Exp Pharmacol; 2006; (175):197-214. PubMed ID: 16722237
[TBL] [Abstract][Full Text] [Related]
29. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.
Wang JQ; McGinty JF
J Neurochem; 1995 Dec; 65(6):2706-15. PubMed ID: 7595569
[TBL] [Abstract][Full Text] [Related]
31. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.
Laćan G; Hadamitzky M; Kuczenski R; Melega WP
Synapse; 2013 Aug; 67(8):476-88. PubMed ID: 23417852
[TBL] [Abstract][Full Text] [Related]
32. The dopamine transporter: a vigilant border control for psychostimulant action.
Williams JM; Galli A
Handb Exp Pharmacol; 2006; (175):215-32. PubMed ID: 16722238
[TBL] [Abstract][Full Text] [Related]
33. Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study.
Booij J; de Bruin K; Gunning WB
Nucl Med Biol; 2006 Apr; 33(3):409-11. PubMed ID: 16631090
[TBL] [Abstract][Full Text] [Related]
34. Sigma2 (sigma2) receptors as a target for cocaine action in the rat striatum.
Nuwayhid SJ; Werling LL
Eur J Pharmacol; 2006 Mar; 535(1-3):98-103. PubMed ID: 16480713
[TBL] [Abstract][Full Text] [Related]
35. Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.
Foster JD; Pananusorn B; Vaughan RA
J Biol Chem; 2002 Jul; 277(28):25178-86. PubMed ID: 11994276
[TBL] [Abstract][Full Text] [Related]
36. Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.
Yorgason JT; Calipari ES; Ferris MJ; Karkhanis AN; Fordahl SC; Weiner JL; Jones SR
Neuropharmacology; 2016 Feb; 101():471-9. PubMed ID: 26525189
[TBL] [Abstract][Full Text] [Related]
37. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
Cowell RM; Kantor L; Hewlett GH; Frey KA; Gnegy ME
Eur J Pharmacol; 2000 Feb; 389(1):59-65. PubMed ID: 10686296
[TBL] [Abstract][Full Text] [Related]
38. Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.
Jayanthi S; McCoy MT; Beauvais G; Ladenheim B; Gilmore K; Wood W; Becker K; Cadet JL
PLoS One; 2009 Jun; 4(6):e6092. PubMed ID: 19564919
[TBL] [Abstract][Full Text] [Related]
39. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
Derbez AE; Mody RM; Werling LL
J Pharmacol Exp Ther; 2002 Apr; 301(1):306-14. PubMed ID: 11907188
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA
Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
